Genentech playing poker with Alzheimer

Your health articles push my buttons.: It's not you. It's the subject. My knowledge of the health industry is only about 5% of what I know about Open Source. That doesn't mean I don't have opinions, well informed or not.

We are loosing the luxuries of outlandish CEO salaries and bonuses. If an airline executive had 15% of the aluminum ripped out of his airline's fleet for scrap to fund his bonus he'd be thrown in a Federal prison never to see the light of day again. But a drug industry executive can play stock shenanigans to pad his bonus and only suffer a sore wrist from glad handing everyone. Making money from making people well is the other side of making money from letting people stay sick.

I know big money buys big advances. It also makes for very expensive drugs. I don't know what the answer is but I do know it has nothing to do with marketing. It has to do with results, not the image of results. It has to do with sharing knowledge not locking it up and charging a fee for it especially when some of that knowledge was publicly funded. It has to do with making a drug that outperforms its predecessor not a sugar pill. And stock prices should be dependent on performance not on successfully lobbying Washington to extend a drug's patent.; Posted by: kozmcrae Posted on: 02/19/09 You are currently: a Guest | Members login | Terms of Use

Reply to Story Reply to Message

Subscribe to this discussion via Email or RSS

| 02/19/09

What do you think?

Here to help you with your Document Management Needs
Doc is an enigma. Born to a Russian ballerina and a German electrical engineer, he grew up in various locations in the United States. He’s seen the insides of more brands, versions, and generations of printer and printer-related hardware than almost anyone.
To learn more about this mysterious figure check out his blog on ZDNet and his Workspace on TechRepublic. You’ll be glad you did.
Produced by
ZDNet and